B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea;B-type natriuretisk peptid i diagnostisering av hjertesvikt hos pasienter med akutt dyspné

Tidsskrift for den Norske Laegeforening

Volumn 123, Issue 15, 2003, Pages 2045-2048

  Knudsen, Cathrine Wold ^a   Westheim, Arne ^a   Omland, Torbjørn ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DYSPNEA; EMERGENCY WARD; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; PROBABILITY; SENSITIVITY ANALYSIS; STANDARDIZATION; ACUTE DISEASE; BLOOD; DIFFERENTIAL DIAGNOSIS; EMERGENCY HEALTH SERVICE; HOSPITAL ADMISSION; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0142121494     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pfeffer MA, Braunwald E, Moye LA, Bast L, Brown EJ, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-77.
2. The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-91.
3. Packer M, Cohn JN, red. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999; 83 (suppl): 1A-38A.
4. Nohria A, Lewis E, Stevensson LW. Medical management of advanced heart failure. JAMA 2002: 287: 628-40.
5. Remes J, Miettinen H, Reunanen A, Pyrorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
6. Stevensson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261: 884-8.
7. Devereaux RB, Liebson PR, Horan MJ. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987; 9 (suppl II): 97-104.
8. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto II et al. Rapid transcription activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an «emergency» cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-7.
9. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-32.
10. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild ventricular impairment, Heart 1996; 76: 232-7.
11. McDonagh TA, Robb SD, Murdoch DR, Morton J, Ford I, Morrison CE et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
12. Maisel AS, Koon J, Krishnaswamy P, Kazanegra R, Clopton P, Gardetto N et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141: 367-74.
13. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111: 274-9.
14. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N et al. A rapid bed-side test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001; 37: 386-91.
15. Omland T, Aakvaag A, Bonarjee WS, Caidahl K, Lie RT, Nilsen DW et al. Plasma brain natriuretic peptide as an indicator of left ventricular systol c function and long-term survival after acute myocardial infarction. Circulation 1996; 93: 1963-9.
16. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Maisel AS. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002; 39: 131-8.
17. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-85.
18. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001; 345: 574-81.
19. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struther AD. Echocardiography in chronic heart failure in the community. Q J Med 1993; 86: 17-23.
20. Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996; 312: 222.
21. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo I. Plasma brain natriuretic peptide in chronic renal failure. Clin Nephr 1995; 44 (suppl 1): 61-4.
22. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
23. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
24. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG et al. B-type natriuretic peptide and clinical judgement in the emergency diagnosis of heart failure. Circulation 2002; 106: 416-22.
25. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7.